EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis

Vi Nguyen iD, Rob Zielinski, Paul Harnett, Katherine Miller iD, Henry Chan, Nikitha Vootakuru, Priya Acharya iD, Montaha Khan, Oliver Gibbs iD, Sarika Gupta iD, Anjla Devi iD, Shani Phillips und 2 weitere

ISRN Hepatology · 2013

DOI: 10.1155/2013/959474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Hepatology, 2013. Verfasst von Vi Nguyen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Sydney, NSW 2145, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

N -terminal probrain natriuretic peptide (NT-proBNP) is a hormone involved in the regulation of cardiovascular homeostasis. Changes in serum NT-proBNP during large volume paracentesis (LVP) in patients with ascites have never before been examined.

Aims

To determine if significant changes in serum NT-proBNP occur in patients undergoing LVP and the associated clinical correlates in patients with cirrhosis.

Method

A total of 45 patients with ascites were prospectively recruited. Serum NT-proBNP, biochemistry, and haemodynamics were determined at baseline and at key time points during and after paracentesis.

Results

34 patients were analysed; 19 had ascites due to cirrhosis and 15 from malignancy. In those with cirrhosis, NT-proBNP decreased by 77.3 pg/mL at 2 L of drainage and 94.3 pg/mL at the end of paracentesis, compared with an increase of 10.5 pg/mL and 77.2 pg/mL in cancer patients at the same time points ( P = 0.05 and P = 0.03 ). Only congestive cardiac failure (CCF) was an independent predictor of significant NT-proBNP changes at the end of drainage in cirrhotic patients ( P < 0.01 ). There were no significant changes in haemodynamics or renal biochemistry for either group.

Conclusion

Significant reductions in serum NT-proBNP during LVP occur in patients with cirrhosis but not malignancy, and only comorbid CCF appeared to predict such changes.

Autor:innen und Institutionen

  • Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Sydney, NSW 2145, Australia.
  • Department of Medical Oncology, Westmead Hospital, Sydney, NSW 2145, Australia.
  • Department of Medicine, Westmead Hospital, Sydney, NSW 2145, Australia.
  • Department of Gastroenterology & Hepatology, Westmead Hospital, Sydney, NSW 2145, Australia.

ORCID-Profile: Vi Nguyen, Katherine Miller, Priya Acharya, Oliver Gibbs, Sarika Gupta, Anjla Devi

Zitieren

APA

Nguyen, V., Zielinski, R., Harnett, P., Miller, K., Chan, H., Vootakuru, N., Acharya, P., Khan, M., Gibbs, O., Gupta, S., Devi, A., Phillips, S., George, J., & van der Poorten, D. (2013). NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis. ISRN Hepatology. https://doi.org/10.1155/2013/959474

Vancouver

Nguyen V, Zielinski R, Harnett P, Miller K, Chan H, Vootakuru N, et al. NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis. ISRN Hepatology. 2013. doi:10.1155/2013/959474

BibTeX
@article{Nguyen2013,
  author = {Nguyen, Vi and Zielinski, Rob and Harnett, Paul and Miller, Katherine and Chan, Henry and Vootakuru, Nikitha and Acharya, Priya and Khan, Montaha and Gibbs, Oliver and Gupta, Sarika and Devi, Anjla and Phillips, Shani and George, Jacob and van der Poorten, David},
  title = {NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis},
  journal = {ISRN Hepatology},
  year = {2013},
  doi = {10.1155/2013/959474}
}
Kostenlos starten →